Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.42 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.42 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.42 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.42 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.42 |
| ▸ | PREP | P48147 | 7/20 | 0.41 |
| ▸ | FAP | Q12884 | 6/20 | 0.41 |
| ▸ | DPP4 | P27487 | 4/20 | 0.41 |
| ▸ | F2 | P00734 | 3/20 | 0.37 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.37 |
| ▸ | ACE | P12821 | 2/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1402277 | 1.00 | CHRM2 (0.42) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29349875 | 0.92 | DPP4 (0.43) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29985759 | 0.91 | PREP (0.44) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL30558194 | 0.88 | FAP (0.40) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL8564777 | 0.88 | DPP4 (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL8564779 | 0.88 | DPP4 (0.46) | CHRM2CHRM4CHRM5CHRM1CHRM3 | |
| SCHEMBL29544133 | 0.86 | ACE (0.50) | ACE | |
| SCHEMBL29613141 | 0.86 | ACE (0.50) | ACE | |
| SCHEMBL30439118 | 0.86 | ACE (0.50) | ACE | |
| SCHEMBL29935652 | 0.86 | CHRM3 (0.42) | CHRM2CHRM4CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8080254-B2 | OB fusion protein compositions and methods | AMGEN, INC. (US) | 2011-12-20 | — | — | US | claimed |
| US-20070224193-A1 | METHODS OF INCREASING LEAN TISSUE MASS USING OB PROTEIN COMPOSITIONS | AMGEN, INC. (US) | 2007-09-27 | — | — | US | claimed |
| US-20070020284-A1 | OB fusion protein compositions and methods | AMGEN, INC. (US) | 2007-01-25 | — | — | US | claimed |
| EP-0954588-B1 | OB FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC (US) | 2007-01-17 | — | — | EP | claimed |
| CN-1335888-A | OPG fusion protein compositions and methods | AMGEN INC (US) | 2002-02-13 | — | — | CN | claimed |
| EP-1127117-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | Amgen Inc., (US) | 2001-08-29 | — | — | EP | claimed |
| WO-2001018203-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2001-03-15 | — | — | WO | claimed |
| WO-2000063253-A1 | AGP-1 FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2000-10-26 | — | — | WO | claimed |
| EP-1961425-B1 | METHODS AND ERYTHROPOEITIN ANALOGS FOR THE PREVENTION AND TREATMENT OF ANEMIA | AMGEN INC (US) | 2017-07-19 | — | — | EP | disclosed |
| US-20150209407-A1 | METHODS FOR THE TREATMENT AND PREVENTION OF OSTEOPOROSIS AND BONE-RELATED DISEASES | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2015-07-30 | — | — | US | disclosed |
| US-20120322730-A1 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ANEMIA | EGRIE JOAN C (US) | 2012-12-20 | — | — | US | disclosed |
| US-8268588-B2 | Methods and compositions for the prevention and treatment of anemia | AMGEN INC. (US) | 2012-09-18 | — | — | US | disclosed |
| US-8080254-B2 | OB fusion protein compositions and methods | AMGEN, INC. (US) | 2011-12-20 | — | — | US | disclosed |
| US-20110256586-A1 | Methods and Compositions for the Prevention and Treatment of Anemia | EGRIE JOAN C | 2011-10-20 | — | — | US | disclosed |
| WO-2001081405-A2 | METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF ANEMIA | AMGEN INC. (US) | 2001-11-01 | — | — | WO | disclosed |
| EP-1140136-A2 | COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF CANCER AND BONE LOSS ASSOCIATED WITH CANCER | Amgen Inc. (US) | 2001-10-10 | — | — | EP | disclosed |
| EP-1127117-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | Amgen Inc., (US) | 2001-08-29 | — | — | EP | disclosed |
| WO-2001018203-A1 | OPG FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| WO-2001017543-A2 | COMPOSITIONS AND METHODS FOR THE PREVENTION OR TREATMENT OF CANCER AND BONE LOSS ASSOCIATED WITH CANCER | AMGEN INC. (US) | 2001-03-15 | — | — | WO | disclosed |
| WO-2000063253-A1 | AGP-1 FUSION PROTEIN COMPOSITIONS AND METHODS | AMGEN INC. (US) | 2000-10-26 | — | — | WO | disclosed |